Posted by Clinical Lab Products | Aug 19, 2009 | Infectious Diseases, Sexually Transmitted Diseases |
Gen-Probe Inc announces that the company has begun a clinical trial intended to secure U.S. regulatory approval of its APTIMA assay for Trichomonas vaginalis on the fully automated TIGRIS system.
Read MorePosted by Clinical Lab Products | Aug 6, 2009 | Miscellaneous |
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
Read MorePosted by Clinical Lab Products | Jul 27, 2009 | Miscellaneous |
Quest Diagnostics Inc announces that the FDA has granted an emergency use authorization to the company’s Focus Diagnostics business for its test for detecting the 2009 H1N1 influenza virus (the “pandemic flu virus”), a strain of influenza A virus initially referred to as the swine flu virus.
Read MorePosted by Clinical Lab Products | Jul 23, 2009 | Sexually Transmitted Diseases |
Research presented today at the American Association for Clinical Chemistry annual meeting shows that an assay developed by Abbott for simultaneous detection of both HIV antigens and antibodies reduced the detection window by zero to nine days in this study compared to HIV antibody-only assays. Earlier detection was shown on four of the five panels tested.
Read MorePosted by Clinical Lab Products | Jun 26, 2009 | Miscellaneous |
Chembio Diagnostic Systems Inc has been awarded a small Business Innovative Research (SBIR) Phase II grant to fully develop, validate, and commercialize a rapid diagnostic test for leptospirosis for general use worldwide.
Read More